China's Sinovac Covid-19 vaccine found highly effective in real world study


Indonesia has seen a drastic drop in hospitalisations and deaths among medical workers after they received the Sinovac vaccine. - Reuters

JAKARTA (Bloomberg): Sinovac Biotech Ltd's vaccine is wiping out Covid-19 among health workers in Indonesia, an encouraging sign for the dozens of developing countries reliant on the controversial Chinese shot, which performed far worse than western vaccines in clinical trials.

Indonesia tracked 25,374 health workers in capital city Jakarta for 28 days after they received their second dose and found that the vaccine protected 100 per cent of them from death and 96 per cent from hospitalisation as soon as seven days after, said Health Minister Budi Gunadi Sadikin in an interview on Tuesday (May 11). The workers were tracked until late February.

Save 30% for ads-free and full access now!

Monthly Plan

RM13.90/month
RM9.73 only

Billed as RM9.73 for the 1st month then RM13.90 thereafters.

Annual Plan

RM12.33/month
RM8.63/month

Billed as RM103.60 for the 1st year then RM148 thereafters.

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Indonesia , China , sinovac , effective , vaccine , covid-19

Others Also Read


All Headlines:

Want to listen to full audio?

Unlock unlimited access to enjoy personalise features on the TheStar.com.my

Already a member? Log In